251 related articles for article (PubMed ID: 36836055)
1. Incidence of Invasive Fungal Infections in Liver Transplant Recipients under Targeted Echinocandin Prophylaxis.
Breitkopf R; Treml B; Simmet K; Bukumirić Z; Fodor M; Senoner T; Rajsic S
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836055
[TBL] [Abstract][Full Text] [Related]
2. Invasive Fungal Breakthrough Infections under Targeted Echinocandin Prophylaxis in High-Risk Liver Transplant Recipients.
Breitkopf R; Treml B; Senoner T; Bukumirić Z; Rajsic S
J Fungi (Basel); 2023 Feb; 9(2):. PubMed ID: 36836384
[TBL] [Abstract][Full Text] [Related]
3. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
[TBL] [Abstract][Full Text] [Related]
4. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.
Winston DJ; Limaye AP; Pelletier S; Safdar N; Morris MI; Meneses K; Busuttil RW; Singh N
Am J Transplant; 2014 Dec; 14(12):2758-64. PubMed ID: 25376267
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation.
Linder KA; Kauffman CA; Patel TS; Fitzgerald LJ; Richards BJ; Miceli MH
Transpl Infect Dis; 2021 Feb; 23(1):e13448. PubMed ID: 33448560
[TBL] [Abstract][Full Text] [Related]
8. A simplified regimen of targeted antifungal prophylaxis in liver transplant recipients: A single-center experience.
Lavezzo B; Patrono D; Tandoi F; Martini S; Fop F; Ballerini V; Stratta C; Skurzak S; Lupo F; Strignano P; Donadio PP; Salizzoni M; Romagnoli R; De Rosa FG
Transpl Infect Dis; 2018 Apr; 20(2):e12859. PubMed ID: 29427394
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
[TBL] [Abstract][Full Text] [Related]
10. Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
Tissot F; Pascual M; Hullin R; Yerly P; Tozzi P; Meylan P; Manuel O
Transplantation; 2014 Jun; 97(11):1192-7. PubMed ID: 24521774
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
[TBL] [Abstract][Full Text] [Related]
12. Targeted versus universal antifungal prophylaxis among liver transplant recipients.
Eschenauer GA; Kwak EJ; Humar A; Potoski BA; Clarke LG; Shields RK; Abdel-Massih R; Silveira FP; Vergidis P; Clancy CJ; Nguyen MH
Am J Transplant; 2015 Jan; 15(1):180-9. PubMed ID: 25359455
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis.
Gatti M; Rinaldi M; Ferraro G; Toschi A; Caroccia N; Arbizzani F; Raschi E; Poluzzi E; Pea F; Viale P; Giannella M
Mycoses; 2021 Nov; 64(11):1317-1327. PubMed ID: 34387004
[TBL] [Abstract][Full Text] [Related]
14. A targeted fungal prophylaxis protocol with static dosed fluconazole significantly reduces invasive fungal infection after liver transplantation.
Jorgenson MR; Descourouez JL; Marka NA; Leverson GE; Smith JA; Andes DR; Fernandez LA; Foley DP
Transpl Infect Dis; 2019 Oct; 21(5):e13156. PubMed ID: 31390109
[TBL] [Abstract][Full Text] [Related]
15. Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study.
Rinaldi M; Bartoletti M; Ferrarese A; Franceschini E; Campoli C; Coladonato S; Pascale R; Tedeschi S; Gatti M; Cricca M; Ambretti S; Siniscalchi A; Morelli MC; Cescon M; Cillo U; Di Benedetto F; Burra P; Mussini C; Cristini F; Lewis R; Viale P; Giannella M
Transpl Infect Dis; 2021 Aug; 23(4):e13608. PubMed ID: 33768656
[TBL] [Abstract][Full Text] [Related]
16. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007).
Raghuram A; Restrepo A; Safadjou S; Cooley J; Orloff M; Hardy D; Butler S; Koval CE
Liver Transpl; 2012 Sep; 18(9):1100-9. PubMed ID: 22577087
[TBL] [Abstract][Full Text] [Related]
17. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.
Wasylyshyn A; Linder KA; Castillo CG; Zhou S; Kauffman CA; Miceli MH
Mycopathologia; 2020 Apr; 185(2):299-306. PubMed ID: 31939052
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and outcome of systemic fungal infections in renal transplant recipients - A tertiary care experience.
Shekar M; Elumalai R; Elayaperumal I; Yelahanka RP; Anandkumar DG; Bandi VK; Matcha J
Saudi J Kidney Dis Transpl; 2019; 30(5):1137-1143. PubMed ID: 31696853
[TBL] [Abstract][Full Text] [Related]
19. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients.
Fortún J; Martín-Davila P; Moreno S; Barcena R; de Vicente E; Honrubia A; García M; Nuño J; Candela A; Uriarte M; Pintado V
J Antimicrob Chemother; 2003 Nov; 52(5):813-9. PubMed ID: 14563893
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.
Corzo-León DE; Satlin MJ; Soave R; Shore TB; Schuetz AN; Jacobs SE; Walsh TJ
Mycoses; 2015 Jun; 58(6):325-36. PubMed ID: 25808822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
